This is a major research line in the Trypanosomatics Lab, which gives rise to a wide variety of projects:
All these projects have in common the ultimate goal of finding new treatments (drugs) for infectious diseases.
Depending on the approach (computational vs hybrid vs experimental), we may target a large number of human pathogens (as in TDR Targets) or may concentrate only on Chagas Disease (American Trypanosomiasis, caused by Trypanosoma cruzi) or on Sleeping Sickness (Human African Trypanosomiasis, HAT, caused by Trypanosoma brucei).
Please check the pages for these subprojects for more information.
PhD Fellow, teacher and science divulgation enthusiast.
Passionate about enzymes and drug discovery.
Former Trypanosomatics Lab Member (2009 – 2014)
Present address: ChEMBL Group (EMBL-EBI)
Principal Investigator, Assistant Professor
Using and generating data to guide discovery of new drugs and diagnostics.